MedPath

Efficacy of inflawell capsules on behavioral and cognitive symptoms and DTI changes in patients with frontotemporal dementia

Phase 2
Conditions
Frontotemporal dementia.
Frontotemporal dementia
G31.0
Registration Number
IRCT20170315033086N8
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Behavioral variant of Frontotemporal dementia based on guideline: Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134
Language variant of Frontotemporal dementia based on guideline: Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006-1014

Exclusion Criteria

Other specific diseases of the central nervous system such as Parkinson's, multifactorial dementia, anterior brain dementia, Huntington's disease, hydrocephalus, brain tumors confirmed by MRI, severe paralysis of the nerve of the supernuclear body, epilepsy, clots between layers of brain tissue, multiple sclerosis and other dementias
Taking NSAIDs and systemic corticosteroids for previous two months continuously
Severe cardiovascular disease, kidney and liver disorders
Psychiatric disorders include bipolar disorder and schizophrenia under medication
Drugs or alcohol abuse
Brain-related surgical interventions
head trauma and progressive degenerative motor disorder
Metabolic and systemic diseases

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in the lesion area of brain. Timepoint: At the commencement of the investigation and 3 months after taking inflawell. Method of measurement: MRI ( Diffusion Tensor Imaging).
Secondary Outcome Measures
NameTimeMethod
Changes in cognitive and behavioral symptoms. Timepoint: At the commencement of the investigation and 3 months after taking inflawell. Method of measurement: Clinical cognitive tests: Behavioral inventory and FTD-Clinical dementia rating (FTD-CDR), Neuropsychiatry inventory (NPI), Frontal assessment buttery (FAB), Persian naming test (PNT).
© Copyright 2025. All Rights Reserved by MedPath